CHSE part of new $112 million AHRQ initiative

05/27/15  Portland, Ore.

EvidenceNOW aims for large-scale improvement in primary care for cardiovascular disease

CHSE will help evaluate a new Agency for Healthcare Research and Quality initiative, announced today, that aims to improve treatment of for 8 million primary-care patients in 12 states around the country.

At $112 million in total funding, the initiative is one of AHRQ's most ambitious ever. It includes seven R18-funded implementation teams in multiple states, along with an overall R01 program evaluation team led by OHSU Family Medicine researcher Deborah Cohen.

The initiatives's quality-improvement goals focus around better use of the "ABCS" (aspirin therapy, blood-pressure control, cholesterol management, and smoking cessation) for patients at risk for heart disease. The evaluation team will observe different practice-change strategies and how they are linked with outcomes.

CHSE Director John McConnell will serve as a co-investigator on the evaluation team's quantitative arm, looking at intervention outcomes and costs, with other CHSE staff supporting. The Oregon Rural Practice-Based Research Network (ORPRN), also at OHSU, will participate in one of the R18 intervention coalitions.

Read the AHRQ announcement.